CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

agen1181

mAbexperimental

Clinical trial activity

29 trials · 29 clinical orgs · 0 marketing orgs

Phase 1
9
Phase 2
20
Phase 3
3
Phase 4
0

Earliest trial started Mar 20, 2019 (NCT03860272)

Timeline

2010s

  1. Jan 1, 2019

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2022

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2024

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07128355Early Phase 1 (Phase 1)Jan 31, 2026Agenus Inc., Harvard University
NCT07152821Phase 3Nov 30, 2025Agenus Inc., Australasian Gastro-Intestinal Trials Group, British Columbia Cancer Agency, Canadian Cancer Trials Group, UNICANCER
NCT07227636Phase 2Nov 7, 2025Agenus Inc., Memorial Sloan-Kettering Cancer Center
NCT07193862Early Phase 1 (Phase 1)Oct 15, 2025Northwell Health
NCT06780787Phase 2Jun 30, 2025City of Hope National Medical Center, National Cancer Institute (NCI)
NCT06843551Phase 2Jun 1, 2025Agenus Inc., University of Miami
NCT06843434Phase 2Feb 20, 2025Agenus Inc., Memorial Sloan-Kettering Cancer Center
NCT06411691Phase 1Nov 4, 2024Agenus Inc., Department of Defense, Johns Hopkins University, National Cancer Institute (NCI), National Institutes of Health (NIH)
NCT06575725Phase 2Nov 1, 2024City of Hope National Medical Center, National Cancer Institute (NCI)
NCT06346197Phase 3Oct 15, 2024Agenus Inc., Centre Leon Berard
NCT06336902Phase 1Oct 1, 2024National Cancer Institute (NCI), University of Southern California
NCT06268015Phase 2Oct 1, 2024Agenus Inc., Duke University, Gateway for Cancer Research
NCT06322108Phase 2May 31, 2024Agenus Inc.
NCT06300463Phase 2Mar 26, 2024Agenus Inc., Cornell University
NCT05864534Phase 2Mar 1, 2024Agenus Inc., CarThera, Northwestern University
NCT06251973Phase 2Feb 1, 2024Memorial Sloan-Kettering Cancer Center
NCT06279130Phase 2/Phase 3 (Phase 3)Jan 29, 2024Agenus Inc., Netherlands Cancer Institute
NCT06076837Phase 1Dec 31, 2023Agenus Inc., HonorHealth Research Institute, TGen Drug Development, University of Arizona
NCT05928806Phase 2Sep 25, 2023Agenus Inc., Georgetown University, Hoosier Cancer Research Network
NCT05845450Phase 2May 11, 2023Gruppo Oncologico del Nord-Ovest, University of Milan
Showing 20 of 29 trials
Page 1 / 2

Organizations

Research & Development (29)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Agenus Inc.For profit21642019
National Cancer Institute (NCI)Government6022023
City of Hope National Medical CenterAcademic/Hospital4412023
Memorial Sloan-Kettering Cancer CenterAcademic/Hospital3312024
Cornell UniversityAcademic/Hospital2212022
Australasian Gastro-Intestinal Trials GroupAcademic/Hospital1012025
British Columbia Cancer AgencyAcademic/Hospital1012025
Canadian Cancer Trials GroupAcademic/Hospital1112025
CarTheraFor profit1012024
Centre Leon BerardAcademic/Hospital1112024
Department of DefenseGovernment1012024
Duke UniversityAcademic/Hospital1112024
Gateway for Cancer ResearchAcademic/Hospital1012024
Georgetown UniversityAcademic/Hospital1012023
Gruppo Oncologico del Nord-OvestAcademic/Hospital1112023
Harvard UniversityAcademic/Hospital1112026
HonorHealth Research InstituteAcademic/Hospital1112023
Hoosier Cancer Research NetworkAcademic/Hospital1112023
Johns Hopkins UniversityAcademic/Hospital1112024
National Institutes of Health (NIH)Government1012024
29 organizations
Page 1 / 2